Jay B. Fell

3.0k total citations
13 papers, 276 citations indexed

About

Jay B. Fell is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Jay B. Fell has authored 13 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Jay B. Fell's work include Computational Drug Discovery Methods (4 papers), Biochemical and Molecular Research (4 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Jay B. Fell is often cited by papers focused on Computational Drug Discovery Methods (4 papers), Biochemical and Molecular Research (4 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Jay B. Fell collaborates with scholars based in United States. Jay B. Fell's co-authors include G. Kumaravel, Bing Yan, Gary M. Coppola, James F. Blake, Jefferson Chin, Isabel Nájera, Steven Swallow, Michael J. Shapiro, James R. Wareing and Sonal Rajyaguru and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Jay B. Fell

13 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jay B. Fell United States	7	162	132	40	24	18	13	276
Dmitry V. Kravchenko Russia	11	225 1.4×	112 0.8×	12 0.3×	33 1.4×	15 0.8×	39	388
Junying Fan United States	8	58 0.4×	113 0.9×	17 0.4×	44 1.8×	6 0.3×	16	211
John W. Butcher United States	11	199 1.2×	180 1.4×	15 0.4×	23 1.0×	46 2.6×	14	407
B. Raju United States	10	160 1.0×	175 1.3×	16 0.4×	14 0.6×	12 0.7×	22	340
Louis‐David Cantin Canada	12	190 1.2×	145 1.1×	26 0.7×	9 0.4×	5 0.3×	14	393
Tony Pateman United Kingdom	6	259 1.6×	94 0.7×	19 0.5×	10 0.4×	24 1.3×	6	392
Thomas M. Judge United States	10	165 1.0×	93 0.7×	36 0.9×	18 0.8×	5 0.3×	14	286
Brett C. Bookser United States	13	226 1.4×	156 1.2×	27 0.7×	13 0.5×	3 0.2×	20	394
Joachim März Germany	11	215 1.3×	216 1.6×	68 1.7×	7 0.3×	4 0.2×	19	492
Xicai Huang Canada	11	252 1.6×	183 1.4×	33 0.8×	18 0.8×	2 0.1×	18	373

Countries citing papers authored by Jay B. Fell

Since Specialization

Citations

This map shows the geographic impact of Jay B. Fell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay B. Fell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay B. Fell more than expected).

Fields of papers citing papers by Jay B. Fell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay B. Fell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay B. Fell. The network helps show where Jay B. Fell may publish in the future.

Co-authorship network of co-authors of Jay B. Fell

This figure shows the co-authorship network connecting the top 25 collaborators of Jay B. Fell. A scholar is included among the top collaborators of Jay B. Fell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay B. Fell. Jay B. Fell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Ren, Li, David Moreno‐Mateos, Brian R. Baer, et al.. (2024). Identification of the Clinical Candidate PF-07284890 (ARRY-461), a Highly Potent and Brain Penetrant BRAF Inhibitor for the Treatment of Cancer. Journal of Medicinal Chemistry. 67(15). 13019–13032. 1 indexed citations

2.

Bouhana, Karyn, Walter E. DeWolf, Li Ren, et al.. (2021). Abstract 1473: Nonclinical development of PF-07284890 (ARRY-461), a potent, brain-penetrant, small molecule inhibitor of BRAF V600-mutation-driven tumors in vitro and in vivo. Cancer Research. 81(13_Supplement). 1473–1473. 4 indexed citations

3.

Marx, Matthew A., Brian R. Baer, Joshua A. Ballard, et al.. (2020). Abstract B30: Structure-based drug discovery of MRTX1257, a selective, covalent KRAS G12C inhibitor with oral activity in animal models of cancer. Molecular Cancer Research. 18(5_Supplement). B30–B30. 5 indexed citations

4.

Christensen, James G., Jay B. Fell, Matthew A. Marx, et al.. (2019). Abstract LB-271: Insight towards therapeutic susceptibility of KRAS mutant cancers from MRTX1257, a novel KRAS G12C mutant selective small molecule inhibitor. LB–271. 2 indexed citations

5.

Christensen, James G., Jay B. Fell, Jill Hallin, et al.. (2019). Abstract C069: The identification of MRTX849, a novel KRASG12C inhibitor under clinical investigation, provides insight toward therapeutic susceptibility of KRAS mutant cancers. Molecular Cancer Therapeutics. 18(12_Supplement). C069–C069. 5 indexed citations

6.

Christensen, James G., Jay B. Fell, Matthew A. Marx, et al.. (2019). Abstract LB-271: Insight towards therapeutic susceptibility of KRAS mutant cancers from MRTX1257, a novel KRAS G12C mutant selective small molecule inhibitor. Cancer Research. 79(13_Supplement). LB–271. 7 indexed citations

7.

Hendricks, R., Jay B. Fell, James F. Blake, et al.. (2009). Non-nucleoside inhibitors of HCV NS5B polymerase. Part 1: Synthetic and computational exploration of the binding modes of benzothiadiazine and 1,4-benzothiazine HCV NS5b polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(13). 3637–3641. 27 indexed citations

8.

Hendricks, R., James F. Blake, Jay B. Fell, et al.. (2008). 3-Hydroxyisoquinolines as inhibitors of HCV NS5b RNA-dependent RNA polymerase. Bioorganic & Medicinal Chemistry Letters. 19(2). 410–414. 46 indexed citations

9.

Aicher, Thomas D., Börk Balkan, Philip Bell, et al.. (1998). Substituted Tetrahydropyrrolo[2,1-b]oxazol-5(6H)-ones and Tetrahydropyrrolo[2,1-b]thiazol-5(6H)-ones as Hypoglycemic Agents. Journal of Medicinal Chemistry. 41(23). 4556–4566. 55 indexed citations

10.

Chin, Jefferson, Jay B. Fell, Mark A. Jarosinski, Michael J. Shapiro, & James R. Wareing. (1998). HPLC/NMR in Combinatorial Chemistry. The Journal of Organic Chemistry. 63(2). 386–390. 30 indexed citations

11.

Brinkman, J. A., et al.. (1996). Squalene synthase inhibitors: isosteric replacements of the farnesyl chain of benzyl farnesyl amine. Bioorganic & Medicinal Chemistry Letters. 6(21). 2491–2494. 5 indexed citations

12.

Yan, Bing, Jay B. Fell, & G. Kumaravel. (1996). Progression of Organic Reactions on Resin Supports Monitored by Single Bead FTIR Microspectroscopy. The Journal of Organic Chemistry. 61(21). 7467–7472. 61 indexed citations

13.

Fell, Jay B. & Gary M. Coppola. (1995). A Mild and Efficient Preparation of Carbodiimides. Synthetic Communications. 25(1). 43–47. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact